German Preclinical Collaborative Research Consortium Reports to have Found Cure for Hepatitis B in Mouse Model

For the first time researchers have succeeded in curing a chronic infection with the hepatitis B virus in a mouse model reports Meaww.

A research collaborative have reported that they have moved closer to a cure for chronic Hepatitis B infection.  The team includes:

Helmholtz Zentrum München
Technical University of Munich
University Medical Center Hamburg-Eppendorf
University Hospital Heidelberg

While thus far researchers haven’t been able to control the virus fully, this German-based research team demonstrated that T cell therapy can provide a permanent cure.

The Promise of T Cell Therapy

The German researchers reported “T cell therapy is a promising means to treat chronic hepatitis B virus (HBV) infection and HBV-associated hepatocellular carcinoma (liver cancer),” stated in their paper published in the Journal of Clinical Investigation. The German team will probe deeper to understand the potential of T-cell therapy and subsequently conduct clinical trials along with their partners.

Hepatitis B: A Major Problem

According to the World Health Organization (WHO) an estimated 257 million people are living with hepatitis B virus infection. Hepatitis B r...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee